T. Rowe Price Associates Reports 2.8% Stake in Alkermes PLC (ALKS) via Amendment No. 2

On May 15, 2026, T. Rowe Price Associates, Inc. filed a Schedule 13G/A (Amendment No. 2) regarding its holdings in Alkermes PLC (ALKS). The filing indicates that as of March 31, 2026, the investment adviser beneficially owns 4,664,563 shares of common stock, representing a 2.8% ownership stake in the company. This reflects an increase from a previous reported position of zero shares, according to the provided metadata. Of the total shares held, T. Rowe Price Associates reported sole voting power over 4,650,687 shares and sole dispositive power over the full 4,664,563 shares. The filing specifies that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. Consequently, because the current ownership level is below the 5% threshold, the filing includes a certification that the reporting person has ceased to be a beneficial owner of more than five percent of the class of securities. T. Rowe Price is based in Baltimore, Maryland, and maintains its principal executive offices there.